These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 32377707

  • 1. PNU282987 inhibits amyloid‑β aggregation by upregulating astrocytic endogenous αB‑crystallin and HSP‑70 via regulation of the α7AChR, PI3K/Akt/HSF‑1 signaling axis.
    Ren Z, Dong Z, Xie P, Lv J, Hu Y, Guan Z, Zhang C, Yu W.
    Mol Med Rep; 2020 Jul; 22(1):201-208. PubMed ID: 32377707
    [Abstract] [Full Text] [Related]

  • 2. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
    Ren Z, Yang M, Guan Z, Yu W.
    Curr Alzheimer Res; 2019 Jul; 16(1):39-48. PubMed ID: 30345917
    [Abstract] [Full Text] [Related]

  • 3. Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway.
    Parada E, Egea J, Romero A, del Barrio L, García AG, López MG.
    Free Radic Biol Med; 2010 Dec 01; 49(11):1815-21. PubMed ID: 20875851
    [Abstract] [Full Text] [Related]

  • 4. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.
    Wang XL, Deng YX, Gao YM, Dong YT, Wang F, Guan ZZ, Hong W, Qi XL.
    Aging (Albany NY); 2020 Jan 06; 12(1):543-570. PubMed ID: 31905173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction.
    Navarro E, Buendia I, Parada E, León R, Jansen-Duerr P, Pircher H, Egea J, Lopez MG.
    Biochem Pharmacol; 2015 Oct 15; 97(4):473-481. PubMed ID: 26212551
    [Abstract] [Full Text] [Related]

  • 11. Heme-Oxygenase I and PCG-1α Regulate Mitochondrial Biogenesis via Microglial Activation of Alpha7 Nicotinic Acetylcholine Receptors Using PNU282987.
    Navarro E, Gonzalez-Lafuente L, Pérez-Liébana I, Buendia I, López-Bernardo E, Sánchez-Ramos C, Prieto I, Cuadrado A, Satrustegui J, Cadenas S, Monsalve M, López MG.
    Antioxid Redox Signal; 2017 Jul 10; 27(2):93-105. PubMed ID: 27554853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.
    Di Cesare Mannelli L, Pacini A, Matera C, Zanardelli M, Mello T, De Amici M, Dallanoce C, Ghelardini C.
    Neuropharmacology; 2014 Apr 10; 79():37-48. PubMed ID: 24225197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Central Activation of Alpha7 Nicotinic Signaling Attenuates LPS-Induced Neuroinflammation and Sickness Behavior in Adult but Not in Aged Animals.
    Navarro E, Norden DM, Trojanowski PJ, Godbout JP, López MG.
    Molecules; 2021 Apr 07; 26(8):. PubMed ID: 33916910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
    Patel H, McIntire J, Ryan S, Dunah A, Loring R.
    J Neuroinflammation; 2017 Sep 26; 14(1):192. PubMed ID: 28950908
    [Abstract] [Full Text] [Related]

  • 20. Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
    Marcus MM, Björkholm C, Malmerfelt A, Möller A, Påhlsson N, Konradsson-Geuken Å, Feltmann K, Jardemark K, Schilström B, Svensson TH.
    Eur Neuropsychopharmacol; 2016 Sep 26; 26(9):1401-1411. PubMed ID: 27474687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.